reference/17287981

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17287981

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	337
issn	0140-6736
issueIdentifier	9431
pageRange	331-337
publicationName	Lancet (London, England)
startingPage	331
bibliographicCitation	Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004 Jul;364(9431):331–7. doi: 10.1016/s0140-6736(04)16721-4. PMID: 15276392.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5e7c92134b4fe5182fa630c9ecd3fab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e1dd5a61c1e08ba6b67f3dfd889f82a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5a6f0b11bdf80d93a8f1c111235a11b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_412694cd1ea337baa7a91df4fd01dec2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12eec7e11c7e11b5cf7a1c429016b80d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4fe9071b26c7fc848886512a20fffbe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0aa75d20fa2557f4adc19101ea19ff83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4408-4392 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18912224f179b1e77f40616345dcbb70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3febfa2b05ea940e6689faaad05d1614
date	200407
identifier	https://doi.org/10.1016/s0140-6736%2804%2916721-4 https://pubmed.ncbi.nlm.nih.gov/15276392
isPartOf	https://portal.issn.org/resource/ISSN/0140-6736 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0021526 http://id.nlm.nih.gov/mesh/M0155432 http://id.nlm.nih.gov/mesh/M0001864
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D020521Q000517 http://id.nlm.nih.gov/mesh/D002546Q000517 http://id.nlm.nih.gov/mesh/D010975Q000008 http://id.nlm.nih.gov/mesh/D013988Q000031 http://id.nlm.nih.gov/mesh/D001241Q000008 http://id.nlm.nih.gov/mesh/D013988Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D013988Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D010975Q000009 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D020300Q000139 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006470Q000139 http://id.nlm.nih.gov/mesh/D001241Q000009 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D000077144 http://id.nlm.nih.gov/mesh/D004311
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6746 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7218 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6895 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9585 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11310 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788943 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790094 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID376229611

Total number of triples: 68.